Generex Biotechnology Corp GNBT:OTCQB

RT Quote | Exchange | USD
Last | 3:58 PM EST
0.43quote price arrow up+0.0283 (+7.05%)
Volume
544,103
52 week range
0.17 - 1.65

...

Loading . . .

KEY STATS

  • Open0.401
  • Day High0.43
  • Day Low0.39
  • Prev Close0.4017
  • 52 Week High1.65
  • 52 Week High Date02/28/20
  • 52 Week Low0.17
  • 52 Week Low Date09/24/20
  • Market Cap47.29M
  • Shares Out109.98M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-1.99
  • 1 Year % Change-23.35

RATIOS/PROFITABILITY

  • EPS (TTM)-0.43
  • P/E (TTM)-0.99
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-26.611M
  • ROE (MRQ)-
  • Revenue (MRQ)2.03M
  • Gross Margin (MRQ)76.85%
  • Net Margin (MRQ)-1,770.48%
  • Debt To Equity (MRQ)-23.13%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Generex Biotechnology Corp News

There is no recent news for this security.

Latest GNBT News From Our Partners

QUOTE FINDER

Profile

MORE
Generex Biotechnology Corporation is a development-stage company. The Company is engaged in the research and development of drug delivery systems and technologies. The Company is involved in the development of a platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones and vaccines. The Company's subsidiary, Antigen Express, Inc. (Antigen), is engaged in research and development of technologies and...
Joseph Moscato
Chairman
Terry Thompson
Chief Operating Officer
Mark Corrao
Chief Financial Officer
Address
10102 USA Today Way
Miramar, FL
33025-3903
United States